Biocorrx (BICX) Stock Price, News & Analysis

Company Overview

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Key Stats

• Today's Range: $0.40 to $0.46
• 50-Day Range: $0.21 to $0.50
• 52-Week Range: $0.20 to $1.45
• Volume: 400 shs
• Average Volume: 992 shs
• Market Capitalization: $8.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

BICX Stock Analysis - Frequently Asked Questions

How have BICX shares performed this year?

Biocorrx's stock was trading at $0.38 at the start of the year. Since then, BICX stock has increased by 5.3% and is now trading at $0.40.

How were Biocorrx's earnings last quarter?

Biocorrx Inc. (OTCMKTS:BICX) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company earned $0.18 million during the quarter.

How do I buy shares of Biocorrx?

Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Biocorrx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biocorrx investors own include PlayAGS (AGS), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Mondi (MNDI), Assertio (ASRT), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 10/18/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:BICX
• CIK: 1443863
• Web: www.biocorrx.com
• Phone: (714) 462-4880
• Fax: N/A
• Employees: 3
• Year Founded: 2008

Profitability

• EPS (Trailing Twelve Months): ($0.35)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.11 million
• Net Margins: N/A
• Pretax Margin: -1,587.86%
• Return on Equity: N/A
• Return on Assets: -130.26%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.04
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 806.40
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.93) per share
• Price / Book: -0.43

Miscellaneous

• Outstanding Shares: 20,160,000
• Free Float: 15,843,000
• Market Cap: $8.06 million
• Optionable: Not Optionable
• Beta: 0.05